Rebleeding after aneurysmal subarachnoid hemorrhage

Neurocritical Care

Volumn 15, Issue 2, 2011, Pages 241-246

  Starke, R M ^a   Connolly Jr , E S ^b  

^a UNIVERSITY OF VIRGINIA   (United States)

^b College of Physicians and Surgeons ^*  (United States)

Author keywords

Antifibrinolytic; Predictor; Ultra early rebleeding

Indexed keywords

AMINOCAPROIC ACID; ANTIFIBRINOLYTIC AGENT; TRANEXAMIC ACID;

BLEEDING; BRAIN ANGIOGRAPHY; BRAIN ISCHEMIA; COIL EMBOLIZATION; DRUG MEGADOSE; ENDOVASCULAR ANEURYSM REPAIR; HUMAN; HYDROCEPHALUS; INCIDENCE; LOADING DRUG DOSE; MICROSURGERY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REBLEEDING; REVIEW; RISK BENEFIT ANALYSIS; RISK FACTOR; SHORT COURSE THERAPY; SUBARACHNOID HEMORRHAGE; SYSTEMATIC REVIEW; TREATMENT DURATION; ACUTE DISEASE; ARTIFICIAL EMBOLISM; INTENSIVE CARE; RECURRENT DISEASE;

ACUTE DISEASE; ANTIFIBRINOLYTIC AGENTS; CRITICAL CARE; EMBOLIZATION, THERAPEUTIC; HUMANS; INCIDENCE; RECURRENCE; RISK FACTORS; SUBARACHNOID HEMORRHAGE;

EID: 84855891431     PISSN: 15416933     EISSN: 15560961     Source Type: Journal    
DOI: 10.1007/s12028-011-9581-0     Document Type: Review

References (47)

1. Ameen AA, Illingworth R. Anti-fibrinolytic treatment in the preoperative management of subarachnoid haemorrhage caused by ruptured intracranial aneurysm. J Neurol Neurosurg Psychiatry. 1981;44:220-6. (Pubitemid 11113196)
2. Fujii Y, Takeuchi S, Sasaki O, Minakawa T, Koike T, Tanaka R. Ultra-early rebleeding in spontaneous subarachnoid hemorrhage. J Neurosurg. 1996;84:35-42. (Pubitemid 26006994)
3. Hillman J, Fridriksson S, Nilsson O, Yu Z, Saveland H, Jakobsson KE. Immediate administration of tranexamic acid and reduced incidence of early rebleeding after aneurysmal subarachnoid hemorrhage: A prospective randomized study. J Neurosurg. 2002;97:771-8. (Pubitemid 35222396)
4. Laidlaw JD, Siu KH. Ultra-early surgery for aneurysmal subarachnoid hemorrhage: Outcomes for a consecutive series of 391 patients not selected by grade or age. J Neurosurg. 2002;97: 250-8. (Pubitemid 34827322)
5. Larsen CC, Eskesen V, Hauerberg J, Olesen C, Romner B, Astrup J. Considerable delay in diagnosis and acute management of subarachnoid haemorrhage. Dan Med Bull. 2010;57:A4139.
6. Harrigan MR, Rajneesh KF, Ardelt AA, Fisher WS 3rd. Shortterm antifibrinolytic therapy before early aneurysm treatment in subarachnoid hemorrhage: Effects on rehemorrhage, cerebral ischemia, and hydrocephalus. Neurosurgery. 2010;67:935-9.
7. Jane JA, Winn HR, Richardson AE. The natural history of intracranial aneurysms: Rebleeding rates during the acute and long term period and implication for surgical management. Clin Neurosurg. 1977;24:176-84.
8. Kassell NF, Torner JC. Aneurysmal rebleeding: A preliminary report from the Cooperative Aneurysm Study. Neurosurgery. 1983; 13:479-81. (Pubitemid 14231935)
9. Kassell NF, Torner JC, Haley EC Jr, Jane JA, Adams HP, Kongable GL. The international cooperative study on the timing of aneurysm surgery. Part 1. Overall management results. J Neurosurg. 1990;73:18-36. (Pubitemid 20206379)
10. Kassell NF, Torner JC, Jane JA, Haley EC Jr, Adams HP. The international cooperative study on the timing of aneurysm surgery. Part 2. Surgical results. J Neurosurg. 1990;73:37-47. (Pubitemid 20206380)
11. Leipzig TJ, Redelman K, Horner TG. Reducing the risk of rebleeding before early aneurysm surgery: A possible role for antifibrinolytic therapy. J Neurosurg. 1997;86:220-5. (Pubitemid 27130681)
12. Molyneux A, Kerr R, Stratton I, et al. International subarachnoid aneurysm trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: A randomised trial. Lancet. 2002;360:1267-74. (Pubitemid 35284616)
13. Molyneux AJ, Kerr RS, Birks J, et al. Risk of recurrent subarachnoid haemorrhage, death, or dependence and standardised mortality ratios after clipping or coiling of an intracranial aneurysm in the International Subarachnoid Aneurysm Trial (ISAT): Long-term follow-up. Lancet Neurol. 2009;8:427-33.
14. Molyneux AJ, Kerr RS, Yu LM, et al. International subarachnoid aneurysm trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: A randomised comparison of effects on survival, dependency, seizures, rebleeding, subgroups, and aneurysm occlusion. Lancet. 2005;366:809-17. (Pubitemid 41557380)
15. Plowman RS, Clarke A, Clarke M, Byrne JV. Sixteen-year single- surgeon experience with coil embolization for ruptured intracranial aneurysms: Recurrence rates and incidence of late rebleeding. J Neurosurg. 2011;114:863-74.
16. Starke RM, Kim GH, Fernandez A, et al. Impact of a policy of early antifibrinolytic therapy for the prevention of acute rebleeding after aneurysmal subarachnoid hemorrhage. Stroke. 2008;39: 2617-21.
17. Cha KC, Kim JH, Kang HI, Moon BG, Lee SJ, Kim JS. Aneurysmal rebleeding: Factors associated with clinical outcome in the rebleeding patients. J Korean Neurosurg Soc. 2010;47:119-23.
18. Tong Y, Gu J, Fan WJ, Yu JB, Pan JW, Wan S, Zhou YQ, Zheng XJ, Zhan RY. Patients with supratentorial aneurismal subarachnoid hemorrhage during the intermediate period: Waiting or actively treating. Int J Neurosci. 2009;119:1494-506.
19. Ruigrok YM, Slooter AJ, Rinkel GJ, Wijmenga C, Rosendaal FR. Genes influencing coagulation and the risk of aneurysmal subarachnoid hemorrhage, and subsequent complications of secondary cerebral ischemia and rebleeding. Acta Neurochir (Wien). 2010;152:257-62.
20. Tanno Y, Homma M, Oinuma M, Kodama N, Ymamoto T. Rebleeding from ruptured intracranial aneurysms in North Eastern Province of Japan. A cooperative study. J Neurol Sci. 2007; 258:11-6. (Pubitemid 46874472)
21. Heelingman CA, van den Bergh WM, Beijer IS, et al. Risk of rebleeding after treatment of acute hydrocephalus in patients with aneurysmal subarachnoid hemorrhage. Stroke. 2007;38:96-9. (Pubitemid 46043195)
22. Machiel Pleizier C, Algra A, Velthuis BK, Rinkel GJ. Relation between size of aneurysms and risk of rebleeding in patients with subarachnoid haemorrhage. Acta Neurochir. 2006;148:1277-9. (Pubitemid 44878782)
23. Beck J, Raabe A, Szelenyi A, et al. Sentinel headache and the risk of rebleeding after aneurysmal subarachnoid hemorrhage. Stroke. 2006;37:2733-7. (Pubitemid 44922534)
24. Kitsua Y, Suzuki N, Sugiyama M, Yamamoto I. Changes in level of consciousness and association with hyperglycemia as tool for predicting and preventing re-bleeding after spontaneous subarachnoid hemorrhage. Prehosp Disaster Med. 2006;21:190-5.
25. Ruijs AC, Dirven CM, Algra A, Beijer I, Vandertop WP, Rinkel G. The risk of rebleeding after external lumbar drainage in patients with untreated ruptured cerebral aneurysms. Acta Neurochir. 2005;147:1157-61.
26. Kusumi M, Yamada M, Kitahara T, et al. Rerupture of cerebral aneurysms during angiography-a retrospective study of 13 patients with subarachnoid hemorrhage. Acta Neurochir. 2005; 147:831-7. (Pubitemid 41103957)
27. Naidech AM, Ianjua N, Kreiter KT, et al. Predictors and impact of aneurysm rebleeding after subarachnoid hemorrhage. Arch Neurol. 2005;62:410-6. (Pubitemid 40349476)
28. McIver JI, Friedman JA, Wijdicks EF, et al. Preoperative ventriculostomy and rebleeding after aneurysmal subarachnoid hemorrhage. J Neurosurg. 2002;97:1042-4. (Pubitemid 35253539)
29. Edner G, Ronne-Engström E. Can early admission reduce aneurysmal rebleeds? A prospective study on aneurysmal incidence, aneurysmal rebleeds, admission and treatment delays in a defined region. Br J Neurosurg. 1991;5:601-8.
30. Steiger HJ, Fritschi J, Seiler RW. Current pattern of in-hospital aneurysmal rebleeds. Analysis of a series treated with individually timed surgery and intravenous nimodipine. Acta Neurochir. 1994;127:21-6. (Pubitemid 24093469)
31. Roos YM, Beenen LM, Goren RM, Albrecht KW, Vermeulen M. Timing of surgery in patients with aneurysmal subarachnoid haemorrhage: Rebleeding is still the major cause of poor outcome in neurosurgical units that aim at early surgery. J Neurol Neurosurg Psychiatry. 1997;63:490-3. (Pubitemid 27423557)
32. Hillman J, von Essen C, Leszniewski W, Johansson I. Significance of "ultra-early" rebleeding in subarachnoid hemorrhage. J Neurosurg. 1988;68:901-7.
33. Larsen CC, Eskesen V, Hauerberg J, Olesen C, Romner B, Astrup J. Considerable delay in diagnosis and acute management of subarachnoid haemorrhage. Ugeskr Laeger. 2010;172:1442.
34. Girvin JP. The use of antifibrinolytic agents in the preoperative treatment of ruptured intracranial aneurysms. Trans Am Neurol Assoc. 1973;98:150-2.
35. van Rossum J, Wintzen AR, Endtz LJ, Schoen JH, de Jonge H. Effect of tranexamic acid on rebleeding after subarachnoid hemorrhage: A double-blind controlled clinical trial. Ann Neurol. 1977;2:238-42.
36. Chandra B. Treatment of subarachnoid hemorrhage from ruptured intracranial aneurysm with tranexamic acid: A double-blind clinical trial. Ann Neurol. 1978;3:502-4. (Pubitemid 8364298)
37. Maurice-Williams RS. Prolonged antifibrinolysis: An effective non-surgical treatment for ruptured intracranial aneurysms? Br Med J. 1978;1:945-7. (Pubitemid 8316492)
38. Kaste M, Ramsay M. Tranexamic acid in subarachnoid hemorrhage. A double-blind study. Stroke. 1979;10:519-22. (Pubitemid 9256240)
39. Fodstad H, Forssell A, Liliequist B, Schannong M. Antifibrinolysis with tranexamic acid in aneurysmal subarachnoid hemorrhage: A consecutive controlled clinical trial. Neurosurgery. 1981;8:158-65. (Pubitemid 11142228)
40. Vermeulen M, Lindsay KW, Murray GD, et al. Antifibrinolytic treatment in subarachnoid hemorrhage. N Engl J Med. 1984; 311:432-7. (Pubitemid 14058254)
41. Tsementzis SA, Hitchcock ER, Meyer CH. Benefits and risks of antifibrinolytic therapy in the management of ruptured intracranial aneurysms. A double-blind placebo-controlled study. Acta Neurochir. 1990;102:1-10. (Pubitemid 20043285)
42. Roos Y. Antifibrinolytic treatment in subarachnoid hemorrhage: A randomized placebo-controlled trial. Star study group. Neurology. 2000;54:77-82. (Pubitemid 30038741)
43. Jane JA, Kassell NF, Torner JC, Winn HR. The natural history of aneurysms and arteriovenous malformations. J Neurosurg. 1985;62:321-3. (Pubitemid 15142173)
44. Kassell NF, Drake CG. Timing of aneurysm surgery. Neurosurgery. 1982;10:514-9. (Pubitemid 12156792)
45. Roos, Y.B., Rinkel, G., Vermeulen, M., Algra, A., van Gijn, J.: Antifibrinolytic therapy for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev. 2003;CD001245.
46. Lylyk P, Miranda C, Ceratto R, et al. Curative endovascular reconstruction of cerebral aneurysms with the pipeline embolization device: The Buenos Aires experience. Neurosurgery. 2009; 64:632-42.
47. Nelson PK, Lylyk P, Szikora I, Wetzel SG, Wanke I, Fiorella D. The pipeline embolization device for the intracranial treatment of aneurysms trial. Am J Neuroradiol. 2011;32:34-40.